Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes

References

• Duell PB, Hagemenas F, Connor WE. The relationship between serum lipoprotein(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care. 1994;17:1135–1140.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Karhapaa P, Rainwater DL, et al. Insulin sensitivity and lipoprotein(a) concentrations in normoglycemic men. Diabetes Care. 1995;18:193–199.
   PubMed Web of Science ®Google Scholar
• DeMeester CA, Bu X, Gray RJ, et al. Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet. 1995;56:287–291.
   PubMed Web of Science ®Google Scholar
• Rainwater DL, Mac Clluer JW, Stern MP, et al. Effect of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes. 1994;43:942–946.
   PubMed Web of Science ®Google Scholar
• Erqou S, Kaptoge S, Perry PL, et al., The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Jama. 2009;302:412–423.
   PubMed Web of Science ®Google Scholar
• Rainwater DL, Haffner SM. Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype. Arterioscler Thromb Vasc Biol. 1998;18:1335–1341.
   PubMed Web of Science ®Google Scholar
• Wang J, Gong J, Li H, et al. Lipoprotein(a) complexes with beta2-glycoprotein I in patients with coronary artery disease. J Atheroscler Thromb. 2012;19:81–89.
   PubMed Web of Science ®Google Scholar
• Lopez LR, Bruckner TR, Hurley BL, et al. Determination of oxidized low-density lipoprotein (ox-LDL) versus oxLDL/beta2-GPI complexes for the assessment of autoimmune-mediated atherosclerosis. Ann N Y Acad Sci. 2007;1109:303–310.
   PubMed Web of Science ®Google Scholar
• Onat A, Can G. Enhanced pro-inflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Design. 2014;20:575–584.
   PubMed Web of Science ®Google Scholar
• Onat A, Çoban N, Can G, et al. Low “quotient” Lp(a) concentration mediating autoimmune activation predicts cardiometabolic risk. Exp Clin Endocr Diabetes. 2015;124:11–18.
   PubMed Web of Science ®Google Scholar
• Koschinsky ML, Marcovina SM. The relationship between lipoprotein(a) and the complications of diabetes mellitus. Acta Diabetol. 2003;40:65–76.
   PubMed Web of Science ®Google Scholar
• Mora S, Kamstrup PR, Rifai N, et al. Lipoprotein(a) and risk of type 2 diabetes. Clin Chem. 2010;56:1252–1260.
   PubMed Web of Science ®Google Scholar
• Ye Z, Haycock PC, Gurdasani D, et al. The association between circulating lipoprotein(a) and type 2 diabetes. Diabetes. 2014;63:332–342.
   PubMed Web of Science ®Google Scholar
• Paige E, Masconi KL, Tsimikas S, et al. Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature. Cardiovasc Diabetol. 2017;16:38.
   PubMed Web of Science ®Google Scholar
• Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 2001;156:1–10.
   PubMed Web of Science ®Google Scholar
• Genuth S, Alberti KG, Bennett P, et al. Expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. The expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:3160–3167.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev. 2000;16:230–236.
   PubMed Web of Science ®Google Scholar
• Hadaegh F, Bozorgmanesh MR, Ghasemi A, et al. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health. 2008;8:176.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qiao Q, Tuomilehto J, et al., for the DECODE/DECODA Study Group. Distinct ethnic differences in lipid profiles across glucose categories. J Clin Endocrinol Metab. 2010;95:1793–1801.
   PubMed Web of Science ®Google Scholar
• Weyer C, Tataranni FA, Pratley RE. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care. 2000;23:779–785.
   PubMed Web of Science ®Google Scholar
• Culver AL, Ockene IS, Balasubramanian R, et al. Statin use and risk of diabetes mellitus in the Women’s Health Initiative. Arch Intern Med. 2012;172:144–152.
   PubMed Web of Science ®Google Scholar
• Gonbert S, Malinsky S, Sposito AC, et al. Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. Atherosclerosis. 2002;164:305–311.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Gruber KK, Morales PA, et al. Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol. 1992;136:1061–1068.
   Web of Science ®Google Scholar
• Siemińska L, Foltyn W, Głogowska-Szeląg J, et al. Relationships between adiponectin, sex hormone binding globulin and insulin resistance in hyperthyroid Graves’ disease women. Endokrynol Pol. 2013;64:26–29.
   PubMed Web of Science ®Google Scholar
• Onat A, Can G, Örnek E, et al. Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk. Eur J Clin Invest. 2013;43:1129–1139.
   PubMed Web of Science ®Google Scholar
• Myasoedova E, Crowson CS, Kremers HM, et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010;69:310–314.
   Web of Science ®Google Scholar
• Onat A, Direskeneli H. Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapy. Curr Pharmaceut Des. 2012;18:1465–1477.
   PubMed Web of Science ®Google Scholar
• Onat A, Can G, Ademoğlu E, et al. Coronary disease risk curve of serum creatinine is linear in Turkish men, U-shaped in women. J Investig Med. 2013;61:27–33.
   PubMed Web of Science ®Google Scholar
• Onat A, Akbaş T, Yüksel H. An inverse-to-anticipated relationship of Lp-PLA2 activity in diabetes: reflection of underlying autoimmune activation. Eur J Intern Med. 2015;26:72.
   PubMed Web of Science ®Google Scholar
• Onat A, Can G, Çiçek G, et al. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes and coronary disease in non-diabetic adults. Acta Diabetol. 2013;50:519–528.
   PubMed Web of Science ®Google Scholar
• Onat A, Hergenç G, Bulur S, et al. The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. Int J Cardiol. 2010;142:72–79.
   PubMed Web of Science ®Google Scholar
• Poon M, Zhang X, Dunsky KG, et al. Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells. Circulation. 1997;96:2514–2519.
   PubMed Web of Science ®Google Scholar